BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16701981)

  • 1. Managing the challenges of invasive fungal infections.
    Herbrecht R
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():1-2. PubMed ID: 16701981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fungal infections in patients undergoing solid organ transplantation].
    Muñoz P; Bouza E
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():34-50. PubMed ID: 9312298
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update on therapy of invasive mycoses in hematology and oncology].
    Maschmeyer G; Haas A; Böhme A
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
    Drew R
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():36-44. PubMed ID: 16713192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 6. Increasing fungal infections in the intensive care unit.
    De Pauw BE
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
    Ryan C; McNicholsan S; O'Connell B; Forde S; Keoghan M; McCann SR
    Hematol J; 2004; 5(6):548-51. PubMed ID: 15570304
    [No Abstract]   [Full Text] [Related]  

  • 8. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. d. Mycoses].
    Mori T; Takahashi M; Ikemoto H
    Nihon Rinsho; 1987 Mar; 45(3):627-31. PubMed ID: 3298740
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of visceral mycoses, with special reference to drug therapy].
    Ikemoto H
    Nihon Rinsho; 1980 Nov; 38(11):4386-92. PubMed ID: 7253229
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.
    Lacerda JF; Oliveira CM
    Clin Drug Investig; 2013 Feb; 33 Suppl 1():S5-14. PubMed ID: 23381977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New challenges to the therapy of systemic fungal infections.
    Medoff G
    Trans Am Clin Climatol Assoc; 1996; 107():146-57; discussion 157-8. PubMed ID: 8725568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
    Böhme A; Karthaus M
    Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?
    Schneemann M; Bachli EB
    Clin Infect Dis; 2004 Jan; 38(2):303-4; author reply 306-7. PubMed ID: 14699468
    [No Abstract]   [Full Text] [Related]  

  • 16. AmBisome: adds to the body of knowledge and familiarity of use.
    Richardson M
    Acta Biomed; 2006; 77 Suppl 4():3-11. PubMed ID: 17370564
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of mycoses of the inner organs].
    Scholer HJ
    Schweiz Med Wochenschr; 1968 Apr; 98(16):602-11. PubMed ID: 5688589
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.